4-Ethyl-1,2,3-thiadiazole-5-carboxylic acid, 95.0%, 2.5g

N-[2-[[4-[4-(3-Bromo-4-fluorophenyl)-4,5-dihydro-5-oxo-1,2,4-oxadiazol-3-yl]-1,2,5-oxadiazol-3-yl]amino]ethyl]sulfamide, 95%, 100mg

2-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)ethanethioamide, 10g

tert-Butyl 4-bromo-1H-pyrrolo[2,3-b]pyridine-1-carboxylate, 95.0%, 25g

N,N-dimethylcyclohexylamine, 99% min, for synthesis, 1L, glass packaging

ETHYL 4-(4-CHLORO-1H-PYRAZOLO[3,4-D]PYRIMIDIN-1-YL)BENZOATE, 95.0%, 5g

2-(3-Bromophenyl)azetidine hydrochloride, 98%, 500mg

6-Hydrazinylpyridine-2-carbohydrazide, 95+%, 250mg

2,6-Bis(benzyloxy)-3-bromopyridine, 97.00%, 1g

Heptan-2-yl 2-chloroacetate, 95+%, 1g

Boc-L-3-carbamoylphenylalanine, 98.0%, 1g

6-Chloro-2-methylindole, 95.0%, 10g

1H-Indole-5-carbohydrazide, 95.0%, 250mg